Cubist Systematic Strategies LLC reduced its stake in Imperva Inc (NASDAQ:IMPV) by 11.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,482 shares of the software maker’s stock after selling 1,487 shares during the period. Cubist Systematic Strategies LLC’s holdings in Imperva were worth $498,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Granahan Investment Management Inc. MA boosted its position in shares of Imperva by 8.0% during the third quarter. Granahan Investment Management Inc. MA now owns 43,580 shares of the software maker’s stock valued at $1,891,000 after buying an additional 3,235 shares during the last quarter. Alyeska Investment Group L.P. boosted its position in shares of Imperva by 89.3% during the third quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock valued at $39,390,000 after buying an additional 428,163 shares during the last quarter. OZ Management LP purchased a new stake in shares of Imperva during the third quarter valued at $3,759,000. Allianz Asset Management GmbH boosted its position in shares of Imperva by 58.1% during the third quarter. Allianz Asset Management GmbH now owns 59,149 shares of the software maker’s stock valued at $2,567,000 after buying an additional 21,732 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Imperva by 171.4% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 475,000 shares of the software maker’s stock valued at $20,702,000 after buying an additional 300,000 shares during the last quarter. 96.93% of the stock is currently owned by hedge funds and other institutional investors.

Imperva Inc (NASDAQ IMPV) opened at $39.95 on Friday. Imperva Inc has a 1-year low of $37.05 and a 1-year high of $52.40. The firm has a market capitalization of $1,360.00, a PE ratio of 147.96 and a beta of 1.78.

Imperva (NASDAQ:IMPV) last posted its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.11. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The company had revenue of $83.89 million for the quarter, compared to the consensus estimate of $83.79 million. During the same quarter in the prior year, the company earned $0.08 earnings per share. Imperva’s revenue was up 22.6% on a year-over-year basis. equities analysts anticipate that Imperva Inc will post -0.52 earnings per share for the current fiscal year.

IMPV has been the topic of several recent analyst reports. BidaskClub raised Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. Zacks Investment Research cut Imperva from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 27th. Wells Fargo & Co cut Imperva from an “outperform” rating to a “market perform” rating in a research report on Monday, October 9th. William Blair cut Imperva from an “outperform” rating to a “market perform” rating in a research report on Tuesday, October 10th. Finally, Imperial Capital dropped their price objective on Imperva from $57.00 to $50.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 10th. Four analysts have rated the stock with a sell rating, six have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $51.86.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/12/29/cubist-systematic-strategies-llc-sells-1487-shares-of-imperva-inc-impv.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.